TSRL Overview

  • Status
  • Private

  • Employees
  • 21

Employees

  • Latest Deal Type
  • Grant

  • Latest Deal Amount
  • $3M

  • Investors
  • 2

TSRL General Information

Description

Developer of preclinical therapeutics intended for severe and multi-drug resistant infections. The company offers infrastructure, expertise, and non-dilutive funding to advance lead candidates into clinical development and the pipeline includes treatments for influenza, adenovirus, and bacterial infections, enabling scientists and business development professionals to leverage infrastructure, and network to remove the barriers to preclinical development, translating promising drug therapy concepts into IND-enabling product opportunities.

Contact Information

Website
www.tsrlinc.com
Ownership Status
Privately Held (backing)
Financing Status
Accelerator/Incubator Backed
Corporate Office
  • 540 Avis Drive
  • Suite A
  • Ann Arbor, MI 48108
  • United States
+1 (734)
Primary Industry
Other Pharmaceuticals and Biotechnology
Corporate Office
  • 540 Avis Drive
  • Suite A
  • Ann Arbor, MI 48108
  • United States
+1 (734)

TSRL Timeline

2022202320242025
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

TSRL Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
5. Grant 25-Apr-2023 $3M Completed Generating Revenue
4. Grant 15-Feb-2022 Completed Generating Revenue
3. Debt - PPP 03-May-2020 Completed Generating Revenue
2. Grant 01-Mar-2017 $1000K Completed Startup
1. Accelerator/Incubator 01-Jan-1987 Completed Startup
To view TSRL’s complete valuation and funding history, request access »

TSRL Patents

  • 41

    Total Documents Applications and Grants

  • Total Patents Families

  • 10

    Granted

  • 4

    Pending

  • Expiring in next 12 mo

TSRL Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
CA-3105038-A1 Metabolically stable prodrugs Pending 26-Jun-2018
EP-3813839-A1 Metabolically stable prodrugs Pending 26-Jun-2018
EP-3813839-A4 Metabolically stable prodrugs Pending 26-Jun-2018
US-20210401992-A1 Metabolically stable prodrugs Pending 26-Jun-2018
JP-2021528465-A Metabolic stability prodrug Active 26-Jun-2018 A61P31/20
To view TSRL’s complete patent history, request access »

TSRL Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

TSRL Investors (2)

Investor Name Investor Type Holding Investor Since Participating Rounds
National Institutes of Health Government
Innovation Partnerships Venture Capital Minority
To view TSRL’s complete investors history, request access »

Ready to get started?

Request a free trial

TSRL FAQs

  • Where is TSRL headquartered?

    TSRL is headquartered in Ann Arbor, MI.

  • What is the size of TSRL?

    TSRL has 21 total employees.

  • What industry is TSRL in?

    TSRL’s primary industry is Other Pharmaceuticals and Biotechnology.

  • Is TSRL a private or public company?

    TSRL is a Private company.

  • What is TSRL’s current revenue?

    The current revenue for TSRL is .

  • Who are TSRL’s investors?

    National Institutes of Health and Innovation Partnerships have invested in TSRL.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »